Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Reshape Lifesciences Inc (RSLS)

Reshape Lifesciences Inc (RSLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,843
  • Shares Outstanding, K 15,842
  • Annual Sales, $ 1,590 K
  • Annual Income, $ -12,330 K
  • 60-Month Beta -1.30
  • Price/Sales 29.03
  • Price/Cash Flow N/A
  • Price/Book 0.46
Trade RSLS with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.81 +7.47%
on 09/14/21
4.04 -25.25%
on 08/19/21
-0.14 (-4.43%)
since 08/17/21
3-Month
2.70 +11.85%
on 08/17/21
8.05 -62.48%
on 06/28/21
-2.87 (-48.73%)
since 06/17/21
52-Week
2.16 +39.81%
on 11/09/20
32.31 -90.65%
on 01/20/21
+0.39 (+14.62%)
since 09/17/20

Most Recent Stories

More News
ReShape Lifesciences(TM) Appoints Al Diaz as Vice President of Operations and Research and Development

ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the appointment of Al Diaz as Vice President of Operations and Research and Development....

RSLS : 3.02 (+3.78%)
ReShape Reports Second Quarter 2021 Financial Results and Provides Business Update

OBLN : 9.15 (-5.86%)
RSLS : 3.02 (+3.78%)
ReShape Lifesciences Reports Preliminary Unaudited Second Quarter 2021 Financial Results and Provides Business Update

SAN CLEMENTE, CA / ACCESSWIRE / August 5, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases,...

RSLS : 3.02 (+3.78%)
ReShape Lifesciences(TM) CEO Bart Bandy Featured on the Big Biz Show

SAN CLEMENTE, CA / ACCESSWIRE / August 3, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced CEO Bart Bandy's featured interview on...

RSLS : 3.02 (+3.78%)
ReShape Lifesciences to Report Second Quarter 2021 Financial and Operational Results on Thursday, August 5, 2021

Webinar will be available discussing recent major milestones that same day

RSLS : 3.02 (+3.78%)
ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress

SAN CLEMENTE, CA / ACCESSWIRE / July 13, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the launch of ™...

RSLS : 3.02 (+3.78%)
ReShape Lifesciences Moves Lap-Band Manufacturing to United States

SAN CLEMENTE, CA / ACCESSWIRE / July 7, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced it has completed their...

APEN : 8.88 (-3.48%)
RSLS : 3.02 (+3.78%)
ReShape Lifesciences Sees Lap-Band Growth as COVID-19 Pandemic Heightens Obesity Crisis

SAN CLEMENTE, CA / ACCESSWIRE / July 1, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight-loss solutions company, today announced that Lap-Band® utilization has increased...

RSLS : 3.02 (+3.78%)
ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders

Funding provides for the acceleration of its internal growth strategy and the continued development of Reshape's weight-loss portfolio

RSLS : 3.02 (+3.78%)
ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds

SAN CLEMENTE, CA / ACCESSWIRE / June 29, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a global weight-loss solutions leader, announced today that it has entered into a warrant exercise agreement with...

RSLS : 3.02 (+3.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA.

See More

Key Turning Points

3rd Resistance Point 3.18
2nd Resistance Point 3.11
1st Resistance Point 3.06
Last Price 3.02
1st Support Level 2.94
2nd Support Level 2.87
3rd Support Level 2.82

See More

52-Week High 32.31
Fibonacci 61.8% 20.79
Fibonacci 50% 17.24
Fibonacci 38.2% 13.68
Last Price 3.02
52-Week Low 2.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar